NCT06506734 Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia
| NCT ID | NCT06506734 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Dental Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-04-07 |
| Primary Completion | 2027-10-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-04-07 with a primary completion date of 2027-10-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this study is to assess the prevalence of dental discoloration (dental dyschromia) in children who experienced high levels of bilirubin in their blood (hyperbilirubinemia) during their early years. The study will also examine risk factors associated with this condition, such as the duration and severity of hyperbilirubinemia, underlying diseases, and treatments received. The researchers hypothesize that the quality of life of individuals with dental dyschromia is lower than that of individuals without dyschromia. The results of this study will be used to discuss coverage for dental care with health insurance for children affected by this condition.
Eligibility Criteria
Inclusion Criteria: * A patient with biliary atresia, progressive familial intrahepatic cholestasis, or Alagille syndrome * Patient or legal representative not opposed to participating in this research. Exclusion Criteria: * Inability to understand and respond to quality of life questionnaires
Contact & Investigator
Nolwen LABORDE, MD
PRINCIPAL INVESTIGATOR
University Hospital, Toulouse
Frequently Asked Questions
Who can join the NCT06506734 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Dental Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06506734 currently recruiting?
Yes, NCT06506734 is actively recruiting participants. Contact the research team at laborde.n@chu-toulouse.fr for enrollment information.
Where is the NCT06506734 trial being conducted?
This trial is being conducted at Bordeaux, France, Caen, France, Lille, France, Lyon, France and 5 additional locations.
Who is sponsoring the NCT06506734 clinical trial?
NCT06506734 is sponsored by University Hospital, Toulouse. The principal investigator is Nolwen LABORDE, MD at University Hospital, Toulouse. The trial plans to enroll 120 participants.